Rafael Muniz, MD

VP, Global Medical Affairs

Rafael assumed the role of Vice President, Global Medical Affairs at MindMed in February 2024.

Tasked with establishing and supervising a comprehensive Global Medical Affairs division, Rafael will drive the formulation and implementation of an integrated medical affairs strategy for MindMed’s diverse pipeline. His leadership and the forthcoming organization will support the Research and Development and Commercial teams during the pre-commercialization phases of MM120 and MM402.

With a background as a psychiatrist trained in the United States, Rafael brings a wealth of experience from a distinguished pharmaceutical career, particularly in Medical Affairs and Clinical Development across prominent U.S. and global enterprises. Having held various esteemed global leadership roles in Medical Affairs, Rafael has successfully established and managed several Medical Affairs entities, contributing significantly to numerous US and Global. product launches. Throughout his tenure in the pharmaceutical industry, Rafael has authored or co-authored over 125 publications.

Rafael earned his MD degree from Universidad Tecnologica de Santiago in Santo Domingo, Dominican Republic, followed by Psychiatry residency training at Bergen Regional Medical Center in Paramus, NJ. He is an active member of the American Medical Association, American Academy of Neurology, American Psychiatric Association and numerous other medical organizations.

Carol Vallone

Chair of the Board of Directors, Chair of Compensation Committee, Member of Audit/Finance Committee

Andreas Krebs

Vice Chair of the Board of Directors, Chair of Nomination and Governance Committee, Member of Audit/Finance Committee

David Gryska

Board Director, Chair of Audit Committee

Roger Crystal, MD

Board Director, Member of Nomination & Governance Committee, Member of Compensation Committee

Robert Barrow

Chief Executive Officer and Board Director

Suzanne Bruhn, PhD

Board Director, Member of Nomination & Governance Committee, Member of Compensation Committee

Miri Halperin Wernli, PhD

Executive President

Daniel Karlin, MD, MA

Chief Medical Officer

Mark Sullivan, JD

Chief Legal Officer and Corporate Secretary

Francois Lilienthal, MD, MBA

Chief Commercial Officer

Carrie Liao, CPA

Chief Accounting Officer

Bridget Walton, MS

VP, Global Regulatory Affairs

Robert Malenka, MD, PhD

Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University

Peter Bergethon, MD

Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.

Robert Dworkin, PhD

Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester

Maurizio Fava, MD

Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)

Carole Abel, MBA

VP, Programs and Portfolio Office (PPO)

Peter Mack, PhD

VP, Pharmaceutical Development

Rafael Muniz, MD

VP, Global Medical Affairs

Phong Duong, PharmD

VP, Global Market Access

Maria Oquendo, MD, PhD

Ruth Meltzer Professor and Chairman of Psychiatry at University of Pennsylvania, Psychiatrist-in-Chief at the Hospital of the University of Pennsylvania

Matthias Liechti, MD, PhD

Scientific Collaborator & Advisor

Kim PC Kuypers, PhD

Scientific Collaborator & Advisor

Peter Gasser, MD

Clinical Advisor